Amogen Pharma
Hyderabad, India amogenpharma.com
From their website, Nov 2026
Work here? Claim this listing
- GLP
- GMP
About
Amogen Pharma develops and manufactures recombinant peptide and protein biosimilars for pharmaceutical partners. It operates from Hyderabad, India, with an office in Basel, Switzerland, and serves programs from early development through commercial supply.
Services
Microbial development services
Genetic engineering, strain development, and microbial development in E. coli and yeast.
Cell line development
Process development
Upstream and downstream process development from bench to commercial scale.
Non-GMP/CGMP manufacturing
Flexible manufacturing from non-GMP toxicology through cGMP clinical and commercial supply.
CDMO: development & manufacturing
Microbial manufacturing services
Production of recombinant proteins and peptides with clinical and commercial supply capabilities.
CDMO: development & manufacturing
Analytical development
Comprehensive analytical method development, qualification, and transfer.
Microbial analytical services
Bioassays, ELISA, microbiology, molecular biology, and related testing support.
Strain development
Development of high-expressing, stable cell lines and strains.
Cell line development
Cell line development
Proprietary platform processes for generating high-expressing, stable cell lines.
Cell line development
Quality services
GMP batch release testing and supporting quality services across the manufacturing lifecycle.
API supply
Supply of recombinant peptide APIs for long-term partnerships.
CDMO: development & manufacturing
FDF licensing
Licensing of finished dosage forms for partner markets.
Co-development
Joint development programs for API and finished dosage form supply.
- Lead time
- NDA signed within 48 hours
- What to send
- Molecule information · Target markets · Development stage · Volume requirements · Analytical package review under NDA
- Minimums and prices
- Volume-linked pricing
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule · Peptide · Recombinant protein · Biosimilar · Peptides · E. coli expression · HPLC · Bioreactors · Process development · Analytical development · qPCR · ELISA
1 more
Toxicology - Capacity
- 75,000 L total fermentation capacity · 100L pre-seed bioreactor x2 · 1000L seed bioreactor x4 · 10,000L production bioreactor x5 · 4 x 10,000L trains · 15,000L production scale · 980 kg semaglutide API capacity annually · 980 kg GLP-1 fermentation output plant · 5 x 15KL production fermenters
- Scales
- Kilogram
- Data supplied
- LC-MS · HPLC
Equipment
- UHPLC
- HPLC-UV/PDA
- LC-MS
- HRMS
- SEC-HPLC
- qPCR
- Preparative Chromatography
Materials
- E. coli
- Yeast
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
GMPSelf-reported
Scope: microbial production facility
Company
- Type
- CRDMO
- Founded
- 2020
- Team
- 75+ Scientific & Manufacturing Experts
Locations
- Based in
- Hyderabad, India
- Sites
- Hyderabad, India · Basel, Switzerland
- Serves
- global, India, UAE, Saudi Arabia, Qatar, Kuwait, Bahrain, Oman, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Canada
Public records
- Parent company
- AMOGEN PHARMA PRIVATE LIMITED · IN GLEIF
Similar labs
Work here? Claim this listing